Published in World J Surg on May 13, 2003
A systematic review and meta-analysis of pylorus-preserving versus classical pancreaticoduodenectomy for surgical treatment of periampullary and pancreatic carcinoma. Ann Surg (2007) 1.55
Laparoscopic versus open approach for solitary insulinoma. Surg Endosc (2006) 1.55
Pancreatic fistula after pancreatectomy: definitions, risk factors, preventive measures, and management-review. Int J Surg Oncol (2012) 1.04
Pancreatic fistula after pancreaticoduodenectomy: the conservative treatment of choice. HPB (Oxford) (2009) 0.99
Anastomotic leakage in pancreatic surgery. HPB (Oxford) (2007) 0.94
Analysis of clinical trials evaluating complications after pancreaticoduodenectomy: a new era of pancreatic surgery. Surg Today (2010) 0.93
Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database Syst Rev (2014) 0.92
Effects of somatostatin prophylaxis after pylorus-preserving pancreaticoduodenectomy: increased delayed gastric emptying and reduced plasma motilin. World J Surg (2005) 0.83
Prospective randomized trial of the effect of octreotide on pancreatic juice output after pancreaticoduodenectomy in relation to histological diagnosis, duct size and leakage. HPB (Oxford) (2012) 0.82
Randomized Controlled Trial of Pancreaticojejunostomy versus Stapler Closure of the Pancreatic Stump During Distal Pancreatectomy to Reduce Pancreatic Fistula. Ann Surg (2016) 0.79
Current surgical management of pancreatic cancer. J Gastrointest Oncol (2011) 0.78
A cost analysis of somatostatin use in the prevention of pancreatic fistula after pancreatectomy. World J Surg (2014) 0.76
Clinical trials to reduce pancreatic fistula after pancreatic surgery-review of randomized controlled trials. Transl Gastroenterol Hepatol (2016) 0.75
Pancreatic Fistula and Delayed Gastric Emptying After Pancreatectomy: Where do We Stand? Indian J Surg (2015) 0.75
Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg (1997) 8.86
Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg (1987) 5.58
THE RATIONALE OF RADICAL SURGERY FOR CANCER OF THE PANCREAS AND AMPULLARY REGION. Ann Surg (1941) 5.25
A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg (1995) 4.24
The complications of pancreatectomy. Ann Surg (1988) 3.40
Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg (2000) 2.94
Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group. Br J Surg (1994) 2.51
Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg (1992) 2.38
Pancreatic fistula and relative mortality in malignant disease after pancreaticoduodenectomy. Review and statistical meta-analysis regarding 15 years of literature. Anticancer Res (1992) 2.03
An analysis of the reduced morbidity and mortality rates after pancreaticoduodenectomy. Arch Surg (1989) 2.02
Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg (1997) 2.00
Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial. Surgery (1995) 1.99
Surgical palliation for pancreatic cancer. The UCLA experience. Ann Surg (1990) 1.73
Pancreatic juice output after pancreatoduodenectomy in relation to pancreatic consistency, duct size, and leakage. Surgery (1996) 1.58
Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy. Br J Surg (1999) 1.47
Pancreatoduodenectomy with occlusion of the residual stump by Neoprene injection. World J Surg (1989) 1.28
Pancreatic and periampullary carcinoma. Experience with 200 patients over a 12 year period. Am J Surg (1982) 1.15
Effects of somatostatin on the exocrine pancreas and the release of duodenal hormones. Metabolism (1978) 1.11
Concomitant benefit of preoperative irradiation in preventing pancreas fistula formation after pancreatoduodenectomy. Arch Surg (1991) 1.09
Treatment of pancreatic cutaneous fistulas with a somatostatin analog. Am J Surg (1988) 1.03
[Prevention of postoperative pancreatic complications following duodenopancreatectomy using somatostatin]. Chirurg (1979) 1.02
Total pancreatic duct drainage for leakproof pancreatojejunostomy. Surgery (1994) 0.98
Historical review of pancreaticoduodenectomy. Am J Surg (1991) 0.97
Surgical treatment of chronic pancreatitis: an overview. Br J Surg (1987) 0.94
Diminishing efficacy of octreotide (SMS 201-995) on gastric functions of healthy subjects during one-week administration. Gastroenterology (1989) 0.89
Effect of octreotide acetate on pancreatic exocrine and endocrine functions after pancreatoduodenal resection. Eur Surg Res (1995) 0.82
Inhibition of pancreatic secretion under long-term octreotide treatment in humans. Digestion (1994) 0.81
Inhibition of exocrine pancreatic secretion by somatostatin and its analogues. Digestion (1994) 0.80
Pharmacokinetics and effects of intravenous infusion of somatostatin in normal subjects--a two-compartment open model. Clin Physiol Biochem (1986) 0.79
Common difficulties and complications in pancreatic surgery. Surg Clin North Am (1991) 0.78
Somatostatin for the prevention of complications following pancreatoduodenectomy. Digestion (1999) 0.77
A simple, secure and universal pancreaticojejunostomy following pancreaticoduodenectomy. HPB Surg (1997) 0.75
The influence of somatostatin on postoperative outcome after elective pancreatic surgery. Acta Chir Belg (1998) 0.75
A review of obturator hernia and a proposed algorithm for its diagnosis and treatment. World J Surg (2005) 2.43
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosage. J Hepatol (2009) 1.82
Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients. Clin Cancer Res (2005) 1.47
Supernumerary intravagal parathyroid hyperplasia. Surgery (2002) 1.38
The pylorus: take it or leave it? Systematic review and meta-analysis of pylorus-preserving versus standard whipple pancreaticoduodenectomy for pancreatic or periampullary cancer. Ann Surg Oncol (2007) 1.24
Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer. Oncology (2004) 1.21
Predictors for patterns of failure after pancreaticoduodenectomy in ampullary cancer. Ann Surg Oncol (2006) 1.16
Tumor size is a major determinant of recurrence in patients with resectable gastrointestinal stromal tumor. Am J Surg (2007) 1.00
Loss of E-cadherin and beta-catenin is correlated with poor prognosis of ampullary neoplasms. J Surg Oncol (2010) 0.98
Overexpression of c-erb-B2 proteins in tumor and non-tumor parts of gastric adenocarcinoma--emphasis on its relation to H. pylori infection and clinicohistological characteristics. Hepatogastroenterology (2002) 0.97
Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery. J Gastroenterol Hepatol (2005) 0.96
Hypoxia-inducible factor-1alpha correlates with MET and metastasis in node-negative breast cancer. Breast Cancer Res Treat (2006) 0.96
Hepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinoma. PLoS One (2012) 0.96
Impact of etiologic factors and APACHE II and POSSUM scores in management and clinical outcome of acute intestinal ischemic disorders after surgical treatment. World J Surg (2006) 0.95
Establishment of an orthotopic transplantable gastric cancer animal model for studying the immunological effects of new cancer therapeutic modules. Mol Carcinog (2010) 0.94
IGF-1 upregulates electroneutral K-Cl cotransporter KCC3 and KCC4 which are differentially required for breast cancer cell proliferation and invasiveness. J Cell Physiol (2007) 0.92
A clustered ground-glass hepatocyte pattern represents a new prognostic marker for the recurrence of hepatocellular carcinoma after surgery. Cancer (2011) 0.91
MRI of gallstones with different compositions. AJR Am J Roentgenol (2004) 0.89
Nested polymerase chain reaction in the diagnosis of negative Ziehl-Neelsen stained Mycobacterium tuberculosis fistula-in-ano: report of four cases. Dis Colon Rectum (2002) 0.88
Estrogen receptor-alpha polymorphism in a Taiwanese clinical breast cancer population: a case-control study. Breast Cancer Res (2004) 0.88
Reconsideration of delayed gastric emptying in pancreaticoduodenectomy. World J Surg (2005) 0.88
Annular pancreas with obstructive jaundice: beware of underlying neoplasm. Pancreas (2002) 0.87
Osteopontin-positive infiltrating tumor-associated macrophages in bulky ampullary cancer predict survival. Cancer Biol Ther (2010) 0.87
Methylation of the CpG sites only on the sense strand of the APC gene is specific for hepatocellular carcinoma. PLoS One (2011) 0.87
Predictors of recurrence after pancreaticoduodenectomy in ampullary cancer: comparison between non-, early and late recurrence. J Formos Med Assoc (2007) 0.86
A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression. Gastroenterology (2013) 0.85
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: a Taiwan cooperative oncology group phase II study. Int J Radiat Oncol Biol Phys (2011) 0.85
Plasma amino acid levels in patients with colorectal cancers and liver cirrhosis with hepatocellular carcinoma. Hepatogastroenterology (2003) 0.84
Zinc deficiency with acrodermatitis enteropathica-like eruption after pancreaticoduodenectomy. J Formos Med Assoc (2007) 0.84
Clinical analysis of the predictive factors for recurrent appendicitis after initial nonoperative treatment of perforated appendicitis. Am J Surg (2006) 0.84
Osteopontin expression is an independent adverse prognostic factor in resectable gastrointestinal stromal tumor and its interaction with CD44 promotes tumor proliferation. Ann Surg Oncol (2010) 0.84
Effects of somatostatin prophylaxis after pylorus-preserving pancreaticoduodenectomy: increased delayed gastric emptying and reduced plasma motilin. World J Surg (2005) 0.83
Predictors for resectability and survival in locally advanced pancreatic cancer after gemcitabine-based neoadjuvant therapy. BMC Surg (2014) 0.82
Early presumptive therapy with fluconazole for occult Candida infection after gastrointestinal surgery. World J Surg (2006) 0.81
Clinical implication and mitotic effect of CD44 cleavage in relation to osteopontin/CD44 interaction and dysregulated cell cycle protein in gastrointestinal stromal tumor. Ann Surg Oncol (2010) 0.81
Significance of CD44 expression in gastrointestinal stromal tumors in relation to disease progression and survival. World J Surg (2007) 0.81
The role of transcatheter arterial embolization in patients with resectable hepatocellular carcinoma: a nation-wide, multicenter study. Liver Int (2004) 0.81
Variation of hepatitis C virus load, hypervariable region 1 quasispecies and CD81 hepatocyte expression in hepatocellular carcinoma and adjacent non-cancerous liver. J Med Virol (2002) 0.80
Effect of pancreaticoduodenectomy on the course of hepatic steatosis. World J Surg (2010) 0.80
Craniofacial gunshot injury resulting in pseudoaneurysm of the left internal maxillary artery and Collet-Sicard syndrome. J Craniofac Surg (2009) 0.80
Impaired emptying of the retained distal stomach causes delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy. World J Surg (2007) 0.80
Stool antigen assay to screen H. pylori infection and to assess the success of 3-Day and 7-Day eradication therapy in the patients with partial gastrectomy. Helicobacter (2002) 0.79
Clinical and imaging characteristics relating to surgical outcomes of perforated appendicitis. Hepatogastroenterology (2008) 0.79
Telomerase activity in tumor and remnant liver as predictor of recurrence and survival in hepatocellular carcinoma after resection. World J Surg (2007) 0.78
The significance of CD44 expression in gastrointestinal neuroendocrine tumors. Hepatogastroenterology (2005) 0.78
Adequate preoperative biliary drainage is determinative to decrease postoperative infectious complications after pancreaticoduodenectomy. Hepatogastroenterology (2010) 0.78
Successfully seal pancreatic end after thermal distal pancreatectomy using needle arrays in alternating electromagnetic fields. Surg Innov (2012) 0.77
Zinc deficiency in patients undergoing pancreatoduodenectomy for periampullary tumors is associated with pancreatic exocrine insufficiency. World J Surg (2011) 0.76
A phase I study of combination of intravenous gemcitabine, oxaliplatin, and 5-FU with daily oral thalidomide (GOFT) in metastatic/locally advanced pancreatic carcinoma patients. Hepatogastroenterology (2008) 0.76
Reduction of intrinsic inhibitory enteric neurons in the antropyloric area in PPPD patients with delayed gastric emptying. Hepatogastroenterology (2005) 0.75
The influence of spleen size on liver regeneration after major hepatectomy in normal and early cirrhotic liver. Liver Int (2005) 0.75
Anti-apoptotic effects of osteopontin through the up-regulation of Mcl-1 in gastrointestinal stromal tumors. World J Surg Oncol (2014) 0.75
Serum tissue polypeptide specific antigen as a noninvasive prognostic indicator for early recurrence of hepatocellular carcinoma after curative resection. Cancer (2002) 0.75
Delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy. J Formos Med Assoc (2004) 0.75
Bloodless liver resection using needle arrays under alternating electromagnetic fields. Surg Innov (2010) 0.75
A De Novo novel mutation of the EDNRB gene in a Taiwanese boy with Hirschsprung disease. J Formos Med Assoc (2006) 0.75
Nonsurgical management of main pancreatic duct transection associated with pseudocyst after blunt abdominal injury. Pancreas (2002) 0.75
Immature intrinsic nerve innervations of pyloric muscle in idiopathic hypertrophic pyloric stenosis. J Formos Med Assoc (2004) 0.75
Surgical decompression in the patients of pancreatic intraductal papillary mucinous neoplasm. Hepatogastroenterology (2007) 0.75